Related Experiment Video
Updated: Jul 17, 2026
07:42
An In vitro Model to Study Heterogeneity of Human Macrophage Differentiation and Polarization
Published on: June 12, 2013
Synthetic prostacyclin analogs differentially regulate macrophage function via distinct analog-receptor binding
David M Aronoff1, Camila M Peres, Carlos H Serezani
1Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Health Systems, Ann Arbor, MI 48109, USA. daronoff@umich.edu
Journal of Immunology (Baltimore, Md. : 1950)
|January 24, 2007
Summary
Prostacyclin (PGI(2)) analogs affect macrophage immune functions differently. Treprostinil uniquely impacts alveolar macrophages, potentially increasing infection risk in patients using these PGI(2)) therapies.
Area of Science:
- Immunology
- Pharmacology
- Prostanoid signaling
Background:
- Prostacyclin (PGI(2)) is crucial for vasodilation and antithrombosis, treating conditions like pulmonary artery hypertension.
- Emerging evidence highlights the role of prostaglandins (PGs), including PGI(2), in regulating innate and adaptive immunity.
- PGI(2)'s instability necessitates the use of analogs, but their immunomodulatory effects require detailed investigation.
Purpose of the Study:
- To investigate the differential effects of PGI(2) analogs (iloprost, carbaprostacyclin, treprostinil) on macrophage innate immune functions.
- To compare the impact of these analogs on alveolar macrophages (AMs) versus peritoneal macrophages (PMs).
- To elucidate the mechanisms underlying treprostinil's unique effects, including potential EP2 receptor involvement.
Main Methods:
- Assessed phagocytosis, bacterial killing, and inflammatory mediator production in rat AMs and PMs exposed to iloprost, carbaprostacyclin, and treprostinil.
- Quantified G(alphas) protein-coupled I prostanoid receptor expression and cAMP generation in both macrophage types.
- Utilized an EP2 receptor antagonist (AH-6809) and EP2-null macrophages to study treprostinil's mechanism.
Main Results:
- Iloprost and carbaprostacyclin showed reduced suppression of AM functions compared to PMs, linked to lower receptor expression and cAMP generation in AMs.
- Treprostinil significantly inhibited AM phagocytosis, bacterial killing, and cytokine production, more so than other analogs.
- Treprostinil's potent effects on AMs were partly attributed to its novel stimulation of the EP2 receptor.
Conclusions:
- Clinically used PGI(2) analogs exhibit distinct immunoregulatory properties, particularly concerning macrophage function.
- Differences in receptor expression and signaling pathways between AMs and PMs contribute to variable analog responses.
- Treprostinil's potent inhibition of AM innate immunity, via EP2 receptor activation, suggests potential implications for infection risk in patients.
Related Concept Videos
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
01:42Phosphoinositides and PIPs
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
01:31Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...